TrialJournal of gastrointestinal cancer2025

Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co-Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study.

Ilya Tsimafeyeu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.